June 27 (UPI) -- Brazil's government announced Saturday that it has signed a $127 million agreement to start producing an experimental COVID-19 vaccine developed by AstraZeneca.
The vaccine developed by AstraZeneca, a British pharmaceutical manufacturer, is considered the world's leading candidate and most likely to be licensed as an official vaccine against the novel coronavirus.